跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial
Approved
STANDARD
ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial
Chiesi Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
7c987774009b8b4d
Company
Chiesi Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7c987774009b8b4d
Product Name
ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial
Artg Id
446710
Artg Name
ELFABRIO pegunigalsidase alfa 20 mg/10 mL concentrated injection vial
Sponsor
Chiesi Australia Pty Ltd
Company Detail Path
/organization/chiesi-australia-pty-ltd
Artg Date
2025-05-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/0c1b6d3d29eca2b14e1ab9bc66ea4fa5.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
7c987774009b8b4d
Type
Standard
Back to TGA Approvals